Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018
Treating hypertension with antihypertensive medications combinations, rather than one medication (ie, monotherapy), is underused in the United States, particularly in certain race/ethnic groups. Identifying factors associated with monotherapy use despite uncontrolled blood pressure (BP) overall and...
Gespeichert in:
| Veröffentlicht in: | The American heart journal 2022-06, Vol.248, p.150-159 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 159 |
|---|---|
| container_issue | |
| container_start_page | 150 |
| container_title | The American heart journal |
| container_volume | 248 |
| creator | Zheutlin, Alexander R. Derington, Catherine G. King, Jordan B. Berchie, Ransmond O. Herrick, Jennifer S. Dixon, Dave L. Cohen, Jordana B. Shimbo, Daichi Kronish, Ian M. Saseen, Joseph J. Muntner, Paul Moran, Andrew E. Bress, Adam P. |
| description | Treating hypertension with antihypertensive medications combinations, rather than one medication (ie, monotherapy), is underused in the United States, particularly in certain race/ethnic groups. Identifying factors associated with monotherapy use despite uncontrolled blood pressure (BP) overall and within race/ethnic groups may elucidate intervention targets in under-treated populations.
Cross-sectional analysis of National Health and Nutrition Examination Surveys (NHANES; 2013-2014 through 2017-2018). We included participants age ≥20 years with hypertension, taking at least one antihypertensive medication, and uncontrolled BP (systolic BP [SBP] ≥ 140 mmHg or diastolic BP [DBP] ≥ 90 mmHg). Demographic, clinical, and healthcare-access factors associated with antihypertensive monotherapy were determined using multivariable-adjusted Poisson regression.
Among 1,597 participants with hypertension and uncontrolled BP, age- and sex- adjusted prevalence of monotherapy was 42.6% overall, 45.4% among non-Hispanic White, 31.9% among non-Hispanic Black, 39.6% among Hispanic, and 50.9% among non-Hispanic Asian adults. Overall, higher SBP was associated with higher monotherapy use, while older age, having a healthcare visit in the previous year, higher body mass index, and having heart failure were associated with lower monotherapy use.
Clinical and healthcare-access factors, including a healthcare visit within the previous year and co-morbid conditions were associated with a higher likelihood of combination antihypertensive therapy. |
| doi_str_mv | 10.1016/j.ahj.2021.10.184 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2583448674</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002870321004361</els_id><sourcerecordid>2656184395</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-d1a5334d4e10f92cfc4500bb67f2e1906ae1c25c425a026b00cf2d8e88f610303</originalsourceid><addsrcrecordid>eNp9kcFu1DAYhCMEokvhAbggS1w4NFvbcZysOFVVS5Gqcig9R479hzhy7MV2FvKmPE6dbAGJAxdb__ibke3JsrcEbwkm_HzYin7YUkzJdpFq9izbELyrcl4x9jzbYIxpXle4OMlehTCkkdOav8xOCsY5LSuyyX5dCxmdD0iE4KQWERT6oWOPhI26n_fgI9igD4BGZ13swYv9jEQavqGHeyTUZGI4OqKH1f7X5WyKUWiy0tnonTHptDXOKbT3EMLkAblDSjRm5doZeSHhHGJvtdRxPkN3IqYUYdANCLPeSqG7KXq9yOjqpxi1XRF0P_kDzIhiUuRpqV9nLzphArx52k-zh-urr5c3-e2XT58vL25zySiLuSKiLAqmGBDc7ajsJCsxbltedRTIDnMBRNIywaXAlLcYy46qGuq64wQXuDjNPhxz9959nyDEZtRBgjHCgptCQ8u6YKxOjST0_T_o4CafXpcoXvLUX7ErE0WOlPQuBA9ds_d6FH5uCG6W2puhSbU3S-2rVC_J756Sp3YE9cfxu-cEfDwCkL7ioME3QWqwEpT2IGOjnP5P_CMBGsGU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2656184395</pqid></control><display><type>article</type><title>Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Zheutlin, Alexander R. ; Derington, Catherine G. ; King, Jordan B. ; Berchie, Ransmond O. ; Herrick, Jennifer S. ; Dixon, Dave L. ; Cohen, Jordana B. ; Shimbo, Daichi ; Kronish, Ian M. ; Saseen, Joseph J. ; Muntner, Paul ; Moran, Andrew E. ; Bress, Adam P.</creator><creatorcontrib>Zheutlin, Alexander R. ; Derington, Catherine G. ; King, Jordan B. ; Berchie, Ransmond O. ; Herrick, Jennifer S. ; Dixon, Dave L. ; Cohen, Jordana B. ; Shimbo, Daichi ; Kronish, Ian M. ; Saseen, Joseph J. ; Muntner, Paul ; Moran, Andrew E. ; Bress, Adam P.</creatorcontrib><description>Treating hypertension with antihypertensive medications combinations, rather than one medication (ie, monotherapy), is underused in the United States, particularly in certain race/ethnic groups. Identifying factors associated with monotherapy use despite uncontrolled blood pressure (BP) overall and within race/ethnic groups may elucidate intervention targets in under-treated populations.
Cross-sectional analysis of National Health and Nutrition Examination Surveys (NHANES; 2013-2014 through 2017-2018). We included participants age ≥20 years with hypertension, taking at least one antihypertensive medication, and uncontrolled BP (systolic BP [SBP] ≥ 140 mmHg or diastolic BP [DBP] ≥ 90 mmHg). Demographic, clinical, and healthcare-access factors associated with antihypertensive monotherapy were determined using multivariable-adjusted Poisson regression.
Among 1,597 participants with hypertension and uncontrolled BP, age- and sex- adjusted prevalence of monotherapy was 42.6% overall, 45.4% among non-Hispanic White, 31.9% among non-Hispanic Black, 39.6% among Hispanic, and 50.9% among non-Hispanic Asian adults. Overall, higher SBP was associated with higher monotherapy use, while older age, having a healthcare visit in the previous year, higher body mass index, and having heart failure were associated with lower monotherapy use.
Clinical and healthcare-access factors, including a healthcare visit within the previous year and co-morbid conditions were associated with a higher likelihood of combination antihypertensive therapy.</description><identifier>ISSN: 0002-8703</identifier><identifier>ISSN: 1097-6744</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/j.ahj.2021.10.184</identifier><identifier>PMID: 34662571</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Adults ; Age ; Antihypertensive Agents - therapeutic use ; Antihypertensives ; Beta blockers ; Blood pressure ; Blood Pressure - physiology ; Body mass ; Body mass index ; Body size ; Cardiovascular disease ; Clinical medicine ; Congestive heart failure ; Cross-Sectional Studies ; Data collection ; Diuretics ; Ethnic factors ; Ethnicity ; Family income ; Health care ; Health facilities ; Health insurance ; Hispanic people ; Humans ; Hypertension ; Hypertension - complications ; Hypertension - drug therapy ; Hypertension - epidemiology ; Minority & ethnic groups ; Nutrition ; Nutrition Surveys ; Polls & surveys ; Race ; United States - epidemiology ; Young Adult</subject><ispartof>The American heart journal, 2022-06, Vol.248, p.150-159</ispartof><rights>2021</rights><rights>Copyright © 2021. Published by Elsevier Inc.</rights><rights>Copyright Elsevier Limited Jun 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-d1a5334d4e10f92cfc4500bb67f2e1906ae1c25c425a026b00cf2d8e88f610303</citedby><cites>FETCH-LOGICAL-c424t-d1a5334d4e10f92cfc4500bb67f2e1906ae1c25c425a026b00cf2d8e88f610303</cites><orcidid>0000-0001-7382-4607 ; 0000-0003-0341-5140 ; 0000-0003-4649-079X ; 0000-0003-0945-2380 ; 0000-0001-6883-6822 ; 0000-0002-5578-782X ; 0000-0001-7560-9521 ; 0000-0001-9257-8843</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002870321004361$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34662571$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zheutlin, Alexander R.</creatorcontrib><creatorcontrib>Derington, Catherine G.</creatorcontrib><creatorcontrib>King, Jordan B.</creatorcontrib><creatorcontrib>Berchie, Ransmond O.</creatorcontrib><creatorcontrib>Herrick, Jennifer S.</creatorcontrib><creatorcontrib>Dixon, Dave L.</creatorcontrib><creatorcontrib>Cohen, Jordana B.</creatorcontrib><creatorcontrib>Shimbo, Daichi</creatorcontrib><creatorcontrib>Kronish, Ian M.</creatorcontrib><creatorcontrib>Saseen, Joseph J.</creatorcontrib><creatorcontrib>Muntner, Paul</creatorcontrib><creatorcontrib>Moran, Andrew E.</creatorcontrib><creatorcontrib>Bress, Adam P.</creatorcontrib><title>Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>Treating hypertension with antihypertensive medications combinations, rather than one medication (ie, monotherapy), is underused in the United States, particularly in certain race/ethnic groups. Identifying factors associated with monotherapy use despite uncontrolled blood pressure (BP) overall and within race/ethnic groups may elucidate intervention targets in under-treated populations.
Cross-sectional analysis of National Health and Nutrition Examination Surveys (NHANES; 2013-2014 through 2017-2018). We included participants age ≥20 years with hypertension, taking at least one antihypertensive medication, and uncontrolled BP (systolic BP [SBP] ≥ 140 mmHg or diastolic BP [DBP] ≥ 90 mmHg). Demographic, clinical, and healthcare-access factors associated with antihypertensive monotherapy were determined using multivariable-adjusted Poisson regression.
Among 1,597 participants with hypertension and uncontrolled BP, age- and sex- adjusted prevalence of monotherapy was 42.6% overall, 45.4% among non-Hispanic White, 31.9% among non-Hispanic Black, 39.6% among Hispanic, and 50.9% among non-Hispanic Asian adults. Overall, higher SBP was associated with higher monotherapy use, while older age, having a healthcare visit in the previous year, higher body mass index, and having heart failure were associated with lower monotherapy use.
Clinical and healthcare-access factors, including a healthcare visit within the previous year and co-morbid conditions were associated with a higher likelihood of combination antihypertensive therapy.</description><subject>Adult</subject><subject>Adults</subject><subject>Age</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Antihypertensives</subject><subject>Beta blockers</subject><subject>Blood pressure</subject><subject>Blood Pressure - physiology</subject><subject>Body mass</subject><subject>Body mass index</subject><subject>Body size</subject><subject>Cardiovascular disease</subject><subject>Clinical medicine</subject><subject>Congestive heart failure</subject><subject>Cross-Sectional Studies</subject><subject>Data collection</subject><subject>Diuretics</subject><subject>Ethnic factors</subject><subject>Ethnicity</subject><subject>Family income</subject><subject>Health care</subject><subject>Health facilities</subject><subject>Health insurance</subject><subject>Hispanic people</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - complications</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - epidemiology</subject><subject>Minority & ethnic groups</subject><subject>Nutrition</subject><subject>Nutrition Surveys</subject><subject>Polls & surveys</subject><subject>Race</subject><subject>United States - epidemiology</subject><subject>Young Adult</subject><issn>0002-8703</issn><issn>1097-6744</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kcFu1DAYhCMEokvhAbggS1w4NFvbcZysOFVVS5Gqcig9R479hzhy7MV2FvKmPE6dbAGJAxdb__ibke3JsrcEbwkm_HzYin7YUkzJdpFq9izbELyrcl4x9jzbYIxpXle4OMlehTCkkdOav8xOCsY5LSuyyX5dCxmdD0iE4KQWERT6oWOPhI26n_fgI9igD4BGZ13swYv9jEQavqGHeyTUZGI4OqKH1f7X5WyKUWiy0tnonTHptDXOKbT3EMLkAblDSjRm5doZeSHhHGJvtdRxPkN3IqYUYdANCLPeSqG7KXq9yOjqpxi1XRF0P_kDzIhiUuRpqV9nLzphArx52k-zh-urr5c3-e2XT58vL25zySiLuSKiLAqmGBDc7ajsJCsxbltedRTIDnMBRNIywaXAlLcYy46qGuq64wQXuDjNPhxz9959nyDEZtRBgjHCgptCQ8u6YKxOjST0_T_o4CafXpcoXvLUX7ErE0WOlPQuBA9ds_d6FH5uCG6W2puhSbU3S-2rVC_J756Sp3YE9cfxu-cEfDwCkL7ioME3QWqwEpT2IGOjnP5P_CMBGsGU</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Zheutlin, Alexander R.</creator><creator>Derington, Catherine G.</creator><creator>King, Jordan B.</creator><creator>Berchie, Ransmond O.</creator><creator>Herrick, Jennifer S.</creator><creator>Dixon, Dave L.</creator><creator>Cohen, Jordana B.</creator><creator>Shimbo, Daichi</creator><creator>Kronish, Ian M.</creator><creator>Saseen, Joseph J.</creator><creator>Muntner, Paul</creator><creator>Moran, Andrew E.</creator><creator>Bress, Adam P.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7382-4607</orcidid><orcidid>https://orcid.org/0000-0003-0341-5140</orcidid><orcidid>https://orcid.org/0000-0003-4649-079X</orcidid><orcidid>https://orcid.org/0000-0003-0945-2380</orcidid><orcidid>https://orcid.org/0000-0001-6883-6822</orcidid><orcidid>https://orcid.org/0000-0002-5578-782X</orcidid><orcidid>https://orcid.org/0000-0001-7560-9521</orcidid><orcidid>https://orcid.org/0000-0001-9257-8843</orcidid></search><sort><creationdate>202206</creationdate><title>Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018</title><author>Zheutlin, Alexander R. ; Derington, Catherine G. ; King, Jordan B. ; Berchie, Ransmond O. ; Herrick, Jennifer S. ; Dixon, Dave L. ; Cohen, Jordana B. ; Shimbo, Daichi ; Kronish, Ian M. ; Saseen, Joseph J. ; Muntner, Paul ; Moran, Andrew E. ; Bress, Adam P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-d1a5334d4e10f92cfc4500bb67f2e1906ae1c25c425a026b00cf2d8e88f610303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adult</topic><topic>Adults</topic><topic>Age</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Antihypertensives</topic><topic>Beta blockers</topic><topic>Blood pressure</topic><topic>Blood Pressure - physiology</topic><topic>Body mass</topic><topic>Body mass index</topic><topic>Body size</topic><topic>Cardiovascular disease</topic><topic>Clinical medicine</topic><topic>Congestive heart failure</topic><topic>Cross-Sectional Studies</topic><topic>Data collection</topic><topic>Diuretics</topic><topic>Ethnic factors</topic><topic>Ethnicity</topic><topic>Family income</topic><topic>Health care</topic><topic>Health facilities</topic><topic>Health insurance</topic><topic>Hispanic people</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - complications</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - epidemiology</topic><topic>Minority & ethnic groups</topic><topic>Nutrition</topic><topic>Nutrition Surveys</topic><topic>Polls & surveys</topic><topic>Race</topic><topic>United States - epidemiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zheutlin, Alexander R.</creatorcontrib><creatorcontrib>Derington, Catherine G.</creatorcontrib><creatorcontrib>King, Jordan B.</creatorcontrib><creatorcontrib>Berchie, Ransmond O.</creatorcontrib><creatorcontrib>Herrick, Jennifer S.</creatorcontrib><creatorcontrib>Dixon, Dave L.</creatorcontrib><creatorcontrib>Cohen, Jordana B.</creatorcontrib><creatorcontrib>Shimbo, Daichi</creatorcontrib><creatorcontrib>Kronish, Ian M.</creatorcontrib><creatorcontrib>Saseen, Joseph J.</creatorcontrib><creatorcontrib>Muntner, Paul</creatorcontrib><creatorcontrib>Moran, Andrew E.</creatorcontrib><creatorcontrib>Bress, Adam P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zheutlin, Alexander R.</au><au>Derington, Catherine G.</au><au>King, Jordan B.</au><au>Berchie, Ransmond O.</au><au>Herrick, Jennifer S.</au><au>Dixon, Dave L.</au><au>Cohen, Jordana B.</au><au>Shimbo, Daichi</au><au>Kronish, Ian M.</au><au>Saseen, Joseph J.</au><au>Muntner, Paul</au><au>Moran, Andrew E.</au><au>Bress, Adam P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>2022-06</date><risdate>2022</risdate><volume>248</volume><spage>150</spage><epage>159</epage><pages>150-159</pages><issn>0002-8703</issn><issn>1097-6744</issn><eissn>1097-6744</eissn><abstract>Treating hypertension with antihypertensive medications combinations, rather than one medication (ie, monotherapy), is underused in the United States, particularly in certain race/ethnic groups. Identifying factors associated with monotherapy use despite uncontrolled blood pressure (BP) overall and within race/ethnic groups may elucidate intervention targets in under-treated populations.
Cross-sectional analysis of National Health and Nutrition Examination Surveys (NHANES; 2013-2014 through 2017-2018). We included participants age ≥20 years with hypertension, taking at least one antihypertensive medication, and uncontrolled BP (systolic BP [SBP] ≥ 140 mmHg or diastolic BP [DBP] ≥ 90 mmHg). Demographic, clinical, and healthcare-access factors associated with antihypertensive monotherapy were determined using multivariable-adjusted Poisson regression.
Among 1,597 participants with hypertension and uncontrolled BP, age- and sex- adjusted prevalence of monotherapy was 42.6% overall, 45.4% among non-Hispanic White, 31.9% among non-Hispanic Black, 39.6% among Hispanic, and 50.9% among non-Hispanic Asian adults. Overall, higher SBP was associated with higher monotherapy use, while older age, having a healthcare visit in the previous year, higher body mass index, and having heart failure were associated with lower monotherapy use.
Clinical and healthcare-access factors, including a healthcare visit within the previous year and co-morbid conditions were associated with a higher likelihood of combination antihypertensive therapy.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34662571</pmid><doi>10.1016/j.ahj.2021.10.184</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-7382-4607</orcidid><orcidid>https://orcid.org/0000-0003-0341-5140</orcidid><orcidid>https://orcid.org/0000-0003-4649-079X</orcidid><orcidid>https://orcid.org/0000-0003-0945-2380</orcidid><orcidid>https://orcid.org/0000-0001-6883-6822</orcidid><orcidid>https://orcid.org/0000-0002-5578-782X</orcidid><orcidid>https://orcid.org/0000-0001-7560-9521</orcidid><orcidid>https://orcid.org/0000-0001-9257-8843</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-8703 |
| ispartof | The American heart journal, 2022-06, Vol.248, p.150-159 |
| issn | 0002-8703 1097-6744 1097-6744 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2583448674 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adult Adults Age Antihypertensive Agents - therapeutic use Antihypertensives Beta blockers Blood pressure Blood Pressure - physiology Body mass Body mass index Body size Cardiovascular disease Clinical medicine Congestive heart failure Cross-Sectional Studies Data collection Diuretics Ethnic factors Ethnicity Family income Health care Health facilities Health insurance Hispanic people Humans Hypertension Hypertension - complications Hypertension - drug therapy Hypertension - epidemiology Minority & ethnic groups Nutrition Nutrition Surveys Polls & surveys Race United States - epidemiology Young Adult |
| title | Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T12%3A23%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20associated%20with%20antihypertensive%20monotherapy%20among%20US%20adults%20with%20treated%20hypertension%20and%20uncontrolled%20blood%20pressure%20overall%20and%20by%20race/ethnicity,%20National%20Health%20and%20Nutrition%20Examination%20Survey%202013-2018&rft.jtitle=The%20American%20heart%20journal&rft.au=Zheutlin,%20Alexander%20R.&rft.date=2022-06&rft.volume=248&rft.spage=150&rft.epage=159&rft.pages=150-159&rft.issn=0002-8703&rft.eissn=1097-6744&rft_id=info:doi/10.1016/j.ahj.2021.10.184&rft_dat=%3Cproquest_cross%3E2656184395%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2656184395&rft_id=info:pmid/34662571&rft_els_id=S0002870321004361&rfr_iscdi=true |